Q2 2025 13F Holders as of 30 Jun 2025
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
58,643,980
-
Total 13F shares
-
61,683,672
-
Share change
-
+1,763,770
-
Total reported value
-
$2,051,725,997
-
Put/Call ratio
-
78%
-
Price per share
-
$33.26
-
Number of holders
-
211
-
Value change
-
+$65,237,833
-
Number of buys
-
107
-
Number of sells
-
100
Institutional Holders of AGIOS PHARMACEUTICALS, INC. - Common Stock (AGIO) as of Q2 2025
As of 30 Jun 2025,
AGIOS PHARMACEUTICALS, INC. - Common Stock (AGIO) was held by
211 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
61,683,672 shares.
The largest 10 holders included
FARALLON CAPITAL MANAGEMENT LLC, VANGUARD GROUP INC, BlackRock, Inc., Bellevue Group AG, Erste Asset Management GmbH, Commodore Capital LP, PRICE T ROWE ASSOCIATES INC /MD/, STATE STREET CORP, MACQUARIE GROUP LTD, and GEODE CAPITAL MANAGEMENT, LLC.
This page lists
211
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.